ClinicalTrials.gg
TerminatedNCT05218187Updated Nov 5, 2026Results posted

Robotic Gait Rehabilitation in Parkinson's Disease

An interventional study of G-EO End-Effector Gait Trainer and Conventional Physical Therapy Treatment in Parkinson Disease and Gait Disorder, Sensorimotor, sponsored by Indiana University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Indiana University · Not applicable, Interventional, and Treatment

How we know

Why this study was terminated
The PI was no longer able to successfully recruit participants and funding was depleted.
Updated Nov 5, 2026Results postedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,650 studies in Parkinson Disease with a site in United States — 305 open to participants now, 387 under way, 7 of them phase 3. Parkinson Disease · United States.

Enrollment
964th of 1,257
15 · median 36
Started
2022
with 104 others
No phase
586 of 1,650
147 open now
Registered
1,230th of 1,650
by date

Among the 1,650 studies in Parkinson Disease with a site in United States, this one is the 964th largest by enrollment of the 1,257 interventional ones that give a count, is one of 105 that started in 2022, is one of 586 with no phase, and was the 1,230th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

305 of the 1,650 studies in Parkinson Disease with a site in United States are open now. Recruiting first, the newest first:

300 more — sign in →

All 305 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,650 studies in Parkinson Disease with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes.

Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability.

Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System.

Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life

Read the detailed description

Individuals diagnosed with Parkinson's disease (PD) often suffer from difficulties with gait initiation, maintaining a consistent kinematic gait pattern, and transitions between gait environments. Focused gait training that provides an environment that can emphasize motor control improvement in these deficits would be ideal for building a rehabilitative foundation for gait recovery for individuals with PD.

One approach that has been used to maintain and restore function in other neurological populations with severe disability is gait rehabilitation using treadmill training. This approach allows for specific and repetitive practice of walking movement and can involve therapist or electromechanical assistance. There is preliminary evidence from two small, uncontrolled studies supporting the benefits of therapist-assisted treadmill training on walking, balance, fatigue, spasticity, muscle strength, and quality of life in patients with PPMS and SPMS. Nevertheless, therapist-assisted gait training can require up to three trainers per patient making it burdensome and inefficient in the clinical setting. The intensity of manual treadmill training is low (i.e., \<1.5 METs) based in part on the physical capacity and fitness level of the trainers, yet physiological adaptations for optimizing outcomes require moderate or vigorous intensity exercise.

Robotic-assisted gait training (RAGT) addresses many of the limitations of therapist-assisted gait training and can be performed using either exoskeleton or end-effector devices. Exoskeleton devices involve programmable drives or passive elements which physically move the lower limbs, whereas, end-effector approaches involve driven footplates that have trajectories that simulate the stance and swing phases. The G-EO System (Reha Technology AG: Olten, Switzerland) is a novel end-effector robotic gait training system that was developed for regaining mobility and independence in stroke survivors. This system involves minimal therapist and patient burden (e.g., quick set-up, single operate usage), there is the unique capacity for practicing walking and stair climbing movements, and the patient can receive real-time visual feedback. Gait training using the G-EO System has been applied in patients with stroke, Multiple Sclerosis (MS), and cerebral palsy (CP). These studies have established safety and feasibility, and preliminary evidence for benefits on mobility and function. For example, two studies involving 4 weeks of G-EO training with conventional physical therapy in non-ambulatory subacute stroke patients reported improved gait, stair climbing ability, leg strength, and activities of daily living (ADL) compared to physical therapy alone. There is limited RAGT studies evaluating the impact of this type of training for individuals with PD. The potential focus on improved gait kinematics may be of particular benefit for PD patients who often struggle with maintain step length and initiation.

The logistic advantages and advanced training capabilities of the G-EO System, as well as the benefits reported in other populations, support this strategy as an effective rehabilitation tool for restoring and maintaining function in Parkinson's disease. This approach represents an opportunity for improving current clinical practices for patients with Parkinson's disease. If successful, this project will provide initial evidence for increasing patient access to the G-EO System, and this could be accomplished through "regional technology centers" using a rural health-delivery approach.

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes.

Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Enrolled participants will be randomized to either conventional physical therapy (CPT) or CPT with G-EO training. Participants will complete baseline assessments on Day 1 and then be scheduled for the intervention phase of the study. Regardless of group allocation, each participant will receive 12 total visits scheduled ideally for twice a week for 6 weeks. Within one week of completing the 12th physical therapy visit, participants will repeat the outcome assessments (post-intervention timepoint). Participants will then be asked to return 30 days later for a final outcome assessment (one month follow-up timepoint).

Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System.

Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life.

03

Conditions studied

  • Parkinson Disease
  • Gait Disorder, Sensorimotor

Keywords

  • End-Effector Gait Training
  • Robot-Assisted Gait Training
  • Mobility
  • Function
  • Quality of Life
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18years
  • Confirmed diagnosis of Parkinson's Disease
  • Hoehn and Yahr stage 1 to 3
  • Stable course of disease-modifying therapy over the past 3 months
  • > 24
  • Physician approval for exercise
  • Stable deep brain stimulation setting for the past year
  • Demonstrate a need for functional rehabilitation

Exclusion criteria

Exclusion Criteria:

    • Severe dyskinesia or severe on-off phenomenon

      • Unstable medication regiment
      • Any co-morbidity that will interfere with walking
      • Conventional physical therapy or G-EO training within the past 6 months
      • Height \<1m or >2m
      • Body weight >150 kg
      • to G-EO gait training (e.g., bone instability)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
15 participants (actual)

Study arms

  • Active comparator
    Conventional Physical Therapy (CPT) Group

    CPT sessions will involve a warm-up using a cycle ergometer or treadmill walking, stretching, progressive strength training exercises, and balance training. Gait training will be provided using traditional over-ground walking. Additional strategies for home exercises, fall prevention, and appropriate assistive devices (i.e., orthotics) will be provided. Training will be administered 2 times per week for 40-60 minutes for six weeks.

    Other: Conventional Physical Therapy Treatment

  • Experimental
    Conventional Physical Therapy (CPT) Group with G-EO Training (CPT-GEO)

    CPT-GEO sessions will involve a warm-up using a cycle ergometer or treadmill walking, stretching, progressive strength training exercises, and balance training. Gait training will be administered using end-effector gait training protocols (G-EO trainer). Training will be administered 2 times per week for 40-60 minutes for six weeks.

    Device: G-EO End-Effector Gait Trainer · Other: Conventional Physical Therapy Treatment

Interventions

  • DeviceG-EO End-Effector Gait Trainer

    The G-EO Gait Trainer uses distal fixation to promote a gait recovery by facilitating a controlled walking environment that includes an over-ground pattern and stair climbing. In addition, the device provides body position control to enable the patient to concentrate on the cyclical motion of walking without the fear of falling. Physical therapists can control different parameters of the gait cycle through computerized adjustments and the training setting can be manipulated to engage patients in active participation.

  • OtherConventional Physical Therapy Treatment

    Therapists will use traditional methods of neurological rehabilitation for improved gait and balance. These approaches will include stretching, strengthening, therapeutic exercises, balance training, and over-ground walking

06

What researchers measure

Primary outcomes

  1. Comfortable Walking Speed (CWS)

    Participants will be asked to walk over a 14-foot pressure mat that will capture their comfortable walking speed. Patients will be instructed to walk at their normal comfortable speed. Walking will begin 5 feet prior to the mat so that each individual walks across the mat at a consistent speed. Participants will pass over the mat 2 times and an average speed will be calculated. It will take 5 minutes to complete this test and will be performed first.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  2. Fast Walking Speed (FWS)

    Participants will be asked to walk over a 14-foot pressure mat that will capture their fast walking speed. Patients will be instructed to walk at their fastest speed while maintaining safe, accurate gait. Walking will begin 5 feet prior to the mat so that each individual walks across the mat at a consistent speed. Participants will pass over the mat 2 times and an average speed will be calculated. It will take 5 minutes to complete this test and will be performed second.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  3. Six Minute Walk Test (6MWT)

    Participants will be asked to walk for 6 minutes along a 30m track that is a flat surface and obstacle free. Subjects may stop and rest as often as needed. Researchers will record the distance traveled during the six minute time period.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

Secondary outcomes

  1. Six Minute Walk Test Walking Speed (6MWT)

    Average walking speed during the 6-Minute Walk Test was measured in meters per second (m/s). Change from baseline was calculated at post-intervention and one-month follow-up. Positive change scores indicate increased average walking speed and improved performance. This is not a scale score.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  2. The Five Times Sit to Stand Test

    The test will quantify functional lower extremity strength. It provides insight into the coordination of functional strength for the accomplishment of transitioning from one posture to another. The participant is asked to safely rise from sitting in a chair to standing and then sit back down five times in a row without using their hands. This test will take about 5 minutes to administer.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  3. Activities-Specific Balance Confidence Scale (ABC)

    The Activities-specific Balance Confidence (ABC) Scale assesses self-reported confidence in maintaining balance while performing activities of daily living. The scale contains 16 items, with each item rated from 0 (no confidence) to 100 (complete confidence). The total ABC score is calculated as the average of the 16 item scores and ranges from 0 to 100. Higher scores indicate greater balance confidence and a better outcome; lower scores indicate less balance confidence and a worse outcome.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  4. Mini-Balance Evaluation Systems Test (MiniBESTest) - Anticipatory Subscale

    The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. The Anticipatory subscale assesses anticipatory postural adjustments during functional movement. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  5. Mini-Balance Evaluation Systems Test (MiniBESTest) - Reactive Postural Control Subscale

    The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. The Reactive Postural Control subscale assesses the ability to recover balance following an external perturbation; examining the effectiveness of compensatory stepping response. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  6. Mini-Balance Evaluation Systems Test (MiniBESTest) - Sensory Orientation Subscale

    The Mini-Balance Evaluation Systems Test (MiniBESTest) evaluates an individual's ability to maintain postural stability when sensory information is altered or conflicting. It assesses how effectively a person uses visual, vestibular, and somatosensory inputs to maintain balance under increasingly challenging conditions. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  7. Mini-Balance Evaluation Systems Test (MiniBESTest) - Dynamic Gait Subscale

    The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. It evaluates an individual's ability to maintain balance while walking under increasingly complex and functionally relevant conditions. It assesses the capacity to adapt gait when confronted with environmental demands, dual-tasking, changes in speed, head movements, obstacle negotiation, and turning. Item scores are summed to produce a subscale score ranging from 0 to 10 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

  8. Parkinson's Disease Questionnaire-39 (PDQ-39) Summary Index Score

    The Parkinson's Disease Questionnaire-39 (PDQ-39) is a 39-item, disease-specific questionnaire assessing health-related quality of life in individuals with Parkinson's disease. It includes eight domains: Mobility, Activities of Daily Living, Emotional Well-being, Stigma, Social Support, Cognitions, Communication, and Bodily Discomfort. Each item is scored from 0 to 4, with higher scores indicating greater difficulty. Individual domain scores are calculated by summing item responses, dividing by the maximum possible domain score, and multiplying by 100. Each domain ranges from 0 to 100. The PDQ-39 Summary Index is calculated as the unweighted mean of the eight domain scores and ranges from 0 to 100. Lower scores indicate better health-related quality of life, while higher scores indicate worse health-related quality of life.

    Time frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit

07

Results

Posted Nov 5, 2026
Limitations and caveats
The study had a small sample size and was conducted at a single specialized neuroscience and rehabilitation center. Follow-up was limited to one month after completion of the intervention. Both groups received active rehabilitation of similar frequency, duration, and intensity; therefore, the study was designed to compare robotic-assisted gait training with conventional overground gait training rather than with a no-treatment control condition.

Participant flow

Participants were recruited through the IU Health Neuroscience Center. Recruitment primarily occurred through physicians specializing in the treatment and management of Parkinson's disease who identified and referred potentially eligible individuals. Physical therapists within the clinical setting also identified potential participants among individuals referred for rehabilitation. Additional recruitment occurred through word of mouth and participant referrals.

Participant flow — Overall Study
MilestoneConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Started96
Completed85
Not completed11
Withdrew: Injury unrelated to study prior to intervention10
Withdrew: Did not initiate assigned intervention01

Outcome measures

PrimaryComfortable Walking Speed (CWS)

Participants will be asked to walk over a 14-foot pressure mat that will capture their comfortable walking speed. Patients will be instructed to walk at their normal comfortable speed. Walking will begin 5 feet prior to the mat so that each individual walks across the mat at a consistent speed. Participants will pass over the mat 2 times and an average speed will be calculated. It will take 5 minutes to complete this test and will be performed first.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Meters/second
Comfortable Walking Speed (CWS)
Meters/secondConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline0.980 ± 0.1850.749 ± 0.235
Post Intervention1.073 ± 0.0980.922 ± 0.313
1 month Follow Up1.112 ± 0.1910.870 ± 0.220
PrimaryFast Walking Speed (FWS)

Participants will be asked to walk over a 14-foot pressure mat that will capture their fast walking speed. Patients will be instructed to walk at their fastest speed while maintaining safe, accurate gait. Walking will begin 5 feet prior to the mat so that each individual walks across the mat at a consistent speed. Participants will pass over the mat 2 times and an average speed will be calculated. It will take 5 minutes to complete this test and will be performed second.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Meters/second
Fast Walking Speed (FWS)
Meters/secondConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline1.398 ± 0.1421.048 ± 0.399
Post Intervention1.520 ± 0.1571.340 ± 0.322
1 month Follow Up1.481 ± 0.1871.267 ± 0.281
PrimarySix Minute Walk Test (6MWT)

Participants will be asked to walk for 6 minutes along a 30m track that is a flat surface and obstacle free. Subjects may stop and rest as often as needed. Researchers will record the distance traveled during the six minute time period.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · meters
Six Minute Walk Test (6MWT)
metersConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline416.70 ± 89.00292.57 ± 170.98
Post Intervention489.38 ± 44.98356.18 ± 89.40
1 month Follow Up473.40 ± 54.86365.44 ± 136.49
SecondarySix Minute Walk Test Walking Speed (6MWT)

Average walking speed during the 6-Minute Walk Test was measured in meters per second (m/s). Change from baseline was calculated at post-intervention and one-month follow-up. Positive change scores indicate increased average walking speed and improved performance. This is not a scale score.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Meters/second
Six Minute Walk Test Walking Speed (6MWT)
Meters/secondConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline1.078 ± 0.2240.808 ± 0.415
Post Intervention0.136 ± 0.2210.110 ± 0.275
1 month Follow Up0.174 ± 0.1570.125 ± 0.261
SecondaryThe Five Times Sit to Stand Test

The test will quantify functional lower extremity strength. It provides insight into the coordination of functional strength for the accomplishment of transitioning from one posture to another. The participant is asked to safely rise from sitting in a chair to standing and then sit back down five times in a row without using their hands. This test will take about 5 minutes to administer.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Seconds
The Five Times Sit to Stand Test
SecondsConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline12.97 ± 1.3719.16 ± 5.25
Post Intervention11.36 ± 1.8017.17 ± 4.19
1 month Follow Up12.20 ± 2.1417.84 ± 2.42
SecondaryActivities-Specific Balance Confidence Scale (ABC)

The Activities-specific Balance Confidence (ABC) Scale assesses self-reported confidence in maintaining balance while performing activities of daily living. The scale contains 16 items, with each item rated from 0 (no confidence) to 100 (complete confidence). The total ABC score is calculated as the average of the 16 item scores and ranges from 0 to 100. Higher scores indicate greater balance confidence and a better outcome; lower scores indicate less balance confidence and a worse outcome.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Scores on a Scale
Activities-Specific Balance Confidence Scale (ABC)
Scores on a ScaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline76.0 ± 9.873.2 ± 23.0
Post Intervention75.6 ± 7.776.4 ± 25.8
1 month Follow Up70.7 ± 10.978.5 ± 24.4
SecondaryMini-Balance Evaluation Systems Test (MiniBESTest) - Anticipatory Subscale

The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. The Anticipatory subscale assesses anticipatory postural adjustments during functional movement. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Score on a scale
Mini-Balance Evaluation Systems Test (MiniBESTest) - Anticipatory Subscale
Score on a scaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline4.25 ± 1.0352.20 ± 1.789
Post Intervention4.50 ± 0.7563.40 ± 2.074
1 month Follow Up3.750 ± 1.9093.00 ± 2.345
SecondaryMini-Balance Evaluation Systems Test (MiniBESTest) - Reactive Postural Control Subscale

The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. The Reactive Postural Control subscale assesses the ability to recover balance following an external perturbation; examining the effectiveness of compensatory stepping response. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Score on a scale
Mini-Balance Evaluation Systems Test (MiniBESTest) - Reactive Postural Control Subscale
Score on a scaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline3.750 ± 1.9823.20 ± 2.049
Post Intervention3.875 ± 0.9912.800 ± 1.789
1 month Follow Up3.375 ± 1.8471.800 ± 1.643
SecondaryMini-Balance Evaluation Systems Test (MiniBESTest) - Sensory Orientation Subscale

The Mini-Balance Evaluation Systems Test (MiniBESTest) evaluates an individual's ability to maintain postural stability when sensory information is altered or conflicting. It assesses how effectively a person uses visual, vestibular, and somatosensory inputs to maintain balance under increasingly challenging conditions. Item scores are summed to produce a subscale score ranging from 0 to 6 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Score on a scale
Mini-Balance Evaluation Systems Test (MiniBESTest) - Sensory Orientation Subscale
Score on a scaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline5.50 ± 0.7564.00 ± 2.00
Post Intervention5.875 ± 0.3545.20 ± 1.304
1 month Follow Up5.00 ± 2.1383.20 ± 2.950
SecondaryMini-Balance Evaluation Systems Test (MiniBESTest) - Dynamic Gait Subscale

The Mini-Balance Evaluation Systems Test (MiniBESTest) is a performance-based measure of dynamic balance. It evaluates an individual's ability to maintain balance while walking under increasingly complex and functionally relevant conditions. It assesses the capacity to adapt gait when confronted with environmental demands, dual-tasking, changes in speed, head movements, obstacle negotiation, and turning. Item scores are summed to produce a subscale score ranging from 0 to 10 points. Higher scores indicate better balance performance and lower scores indicate greater balance impairment.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Score on a scale
Mini-Balance Evaluation Systems Test (MiniBESTest) - Dynamic Gait Subscale
Score on a scaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline7.50 ± 1.7735.60 ± 3.209
Post Intervention8.50 ± 1.0697.20 ± 2.168
1 month Follow Up7.875 ± 3.4825.20 ± 3.834
SecondaryParkinson's Disease Questionnaire-39 (PDQ-39) Summary Index Score

The Parkinson's Disease Questionnaire-39 (PDQ-39) is a 39-item, disease-specific questionnaire assessing health-related quality of life in individuals with Parkinson's disease. It includes eight domains: Mobility, Activities of Daily Living, Emotional Well-being, Stigma, Social Support, Cognitions, Communication, and Bodily Discomfort. Each item is scored from 0 to 4, with higher scores indicating greater difficulty. Individual domain scores are calculated by summing item responses, dividing by the maximum possible domain score, and multiplying by 100. Each domain ranges from 0 to 100. The PDQ-39 Summary Index is calculated as the unweighted mean of the eight domain scores and ranges from 0 to 100. Lower scores indicate better health-related quality of life, while higher scores indicate worse health-related quality of life.

Time frame:
Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
Reported as:
Mean · Units on a scale
Parkinson's Disease Questionnaire-39 (PDQ-39) Summary Index Score
Units on a scaleConventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)
Baseline25.05 ± 8.3930.08 ± 17.07
Post Intervention25.59 ± 11.2925.08 ± 13.96
1 month Follow Up26.68 ± 9.1414.06 ± 5.51

Adverse events

Collected over Adverse events were monitored throughout the 6-week intervention period and through the one-month follow-up assessment.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Conventional Physical Therapy (CPT) Group0/8 (0%)0/8 (0%)0/8 (0%)
Conventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Conventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)Total
Mean76 (68 to 81)66 (50 to 75)70 (50 to 81)
Sex: Female, Male
Sex: Female, Male(Participants)Conventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)Total
Female112
Male7411
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Conventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)Total
Count of participants——0
10 Meter Walk Test
10 Meter Walk Test(Meters/second)Conventional Physical Therapy (CPT) GroupConventional Physical Therapy (CPT) Group With G-EO Training (CPT-GEO)Total
Comfortable Walking Speed0.980 ± .1850.749 ± 0.2350.891 ± 0.228
Fast Walking Speed1.398 ± 0.1421.048 ± 0.3991.264 ± 0.310
08

Study locations

1 site
  • IU Health Neurorehabilitation and Robotics
    Indianapolis, Indiana 46202, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — It is not determined at this time.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2022 to primary completion in Aug 2025, 43 months.

Results were first posted in Nov 2026, 1 year 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2022
First posted
Feb 1, 2022
StartActual
Jan 10, 2022
Primary completionActual
Aug 22, 2025
CompletionActual
Aug 22, 2025
Results first posted
Nov 5, 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 5, 2026
Secondary outcomes
1 edited, 4 added, 1 removed, 2 description edited
What changed in the outcomes
  • EditedParkinson's diseaseDisease Questionnaire-39 (PDQ39PDQ-39) Summary Index ScoreTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Anticipatory SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Reactive Postural Control SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Sensory Orientation SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Dynamic Gait SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • RemovedMini BESTestTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
  • DescriptionActivities-Specific Balance Confidence Scale (ABC): how it is measured was reworded
  • DescriptionSix Minute Walk Test Walking Speed (6MWT): how it is measured was reworded
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Results posted
    Secondary outcomes 1 edited, 4 added, 1 removed, 2 description edited
    What changed in the outcomes
    • EditedParkinson's diseaseDisease Questionnaire-39 (PDQ39PDQ-39) Summary Index ScoreTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Anticipatory SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Reactive Postural Control SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Sensory Orientation SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • AddedMini-Balance Evaluation Systems Test (MiniBESTest) - Dynamic Gait SubscaleTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • RemovedMini BESTestTime frame: Baseline, Post-Intervention (within 1 week after last therapy session), and 30 days after Post-intervention Visit
    • DescriptionActivities-Specific Balance Confidence Scale (ABC): how it is measured was reworded
    • DescriptionSix Minute Walk Test Walking Speed (6MWT): how it is measured was reworded
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05218187
Lead sponsor
Indiana University
Responsible party
Peter Altenburger (Associate Professor, Indiana University) — Principal investigator
First posted
Feb 1, 2022
Start date
Jan 10, 2022
Primary completion
Aug 22, 2025
Completion
Aug 22, 2025
Results posted
Nov 5, 2026
Last update
Nov 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion